Elevance Health, Inc.

Sanders Capital, LLC ELV

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

5,750,865

Value ($000)

2,015,966

Weight

2.3%

2014 Q4 - 2025 Q4 (45 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	2,015,966	2.3%	5,750,865	12/31/2025
2025 Q3	11/13/2025	1,864,053	2.3%	5,768,918	9/30/2025
2025 Q2	8/8/2025	2,265,773	3.0%	5,825,208	6/30/2025
2025 Q1	5/14/2025	2,032,467	3.0%	4,672,768	3/31/2025
2024 Q4	2/13/2025	1,728,722	2.5%	4,686,154	12/31/2024
2024 Q3	11/13/2024	2,396,814	3.5%	4,609,258	9/30/2024
2024 Q2	8/9/2024	2,473,295	3.8%	4,564,453	6/30/2024
2024 Q1	5/10/2024	2,337,162	3.9%	4,507,197	3/31/2024
2023 Q4	2/12/2024	2,102,208	3.9%	4,457,986	12/31/2023
2023 Q3	11/9/2023	1,855,750	3.9%	4,261,976	9/30/2023
2023 Q2	8/11/2023	1,867,779	3.9%	4,203,963	6/30/2023
2023 Q1	5/10/2023	1,847,357	4.4%	4,017,654	3/31/2023
2022 Q4	2/10/2023	1,991,235	5.2%	3,881,777	12/31/2022
2022 Q3	11/14/2022	1,801	5.0%	3,964,817	9/30/2022
2022 Q2	8/12/2022	1,968	5.0%	4,078,091	6/30/2022
2022 Q1	8/24/2022	2,005	4.4%	4,081,861	3/31/2022
2021 Q4	8/25/2022	1,874	3.8%	4,042,601	12/31/2021
2021 Q3	8/24/2022	1,483	3.4%	3,977,162	9/30/2021
2021 Q2	8/24/2022	1,392	3.2%	3,646,220	6/30/2021
2021 Q1	8/24/2022	1,258	3.0%	3,505,947	3/31/2021
2020 Q4	9/7/2022	1,108	2.9%	3,450,167	12/31/2020
2020 Q3	9/7/2022	824	2.8%	3,068,920	9/30/2020
2020 Q2	9/7/2022	745	2.8%	2,831,352	6/30/2020
2020 Q1	9/7/2022	615	2.9%	2,710,785	3/31/2020
2019 Q4	9/7/2022	791	2.8%	2,617,744	12/31/2019
2019 Q3	9/7/2022	551	2.5%	2,295,671	9/30/2019
2019 Q2	9/7/2022	620	2.8%	2,196,547	6/30/2019
2019 Q1	9/7/2022	572,567	2.7%	1,995,147	3/31/2019
2018 Q4	9/7/2022	479,057	2.7%	1,824,077	12/31/2018
2018 Q3	9/7/2022	495,320	2.5%	1,807,407	9/30/2018
2018 Q2	9/7/2022	446,788	2.4%	1,877,022	6/30/2018
2018 Q1	9/7/2022	411,832	2.3%	1,874,522	3/31/2018
2017 Q4	9/7/2022	422,709	2.3%	1,878,622	12/31/2017
2017 Q3	9/7/2022	349,345	2.1%	1,839,822	9/30/2017
2017 Q2	9/7/2022	379,497	2.4%	2,017,208	6/30/2017
2017 Q1	9/7/2022	375,324	2.5%	2,196,328	3/31/2017
2016 Q4	9/7/2022	370,388	2.6%	2,576,254	12/31/2016
2016 Q3	9/7/2022	295,220	2.3%	2,355,920	9/30/2016
2016 Q2	9/7/2022	375,221	3.1%	2,856,865	6/30/2016
2016 Q1	9/7/2022	403,054	3.5%	2,899,875	3/31/2016
2015 Q4	9/7/2022	346,757	3.2%	2,486,781	12/31/2015
2015 Q3	9/7/2022	279,101	2.8%	1,993,581	9/30/2015
2015 Q2	9/7/2022	326,849	3.1%	1,991,281	6/30/2015
2015 Q1	9/7/2022	308,004	3.0%	1,994,715	3/31/2015
2014 Q4	9/7/2022	258,895	2.6%	2,060,115	12/31/2014